StockData
Enveric Biosciences, Inc. logo

Enveric Biosciences, Inc. (ENVB) stock

ENVBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.41−0.03 (-2.08%)

Close on Nov 17, 2026Market cap $6.31MP/E –Yield –

Enveric Biosciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Enveric Biosciences's revenue for the twelve months ending Sep 30, 2020 was $35.41M, down 13.9% year over year. For fiscal 2019 it was $39.91M, down 7.2% from the year before. The highest annual figure on record is $48.59M in fiscal 2017.

Annual revenue

PeriodPeriod endValueChange
FY2019Dec 31, 2019$39.91M-7.2%
FY2018Dec 31, 2018$43.00M-11.5%
FY2017Dec 31, 2017$48.59M+34.4%
FY2016Dec 31, 2016$36.15M+78.4%
FY2015Dec 31, 2015$20.26M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2020Sep 30, 2020$8.48M-7.3%
Q2 FY2020Jun 30, 2020$8.25M-25.1%
Q1 FY2020Mar 31, 2020$9.60M-10.1%
Q4 FY2019Dec 31, 2019$9.06M-11.9%
Q3 FY2019Sep 30, 2019$9.15M-13.5%
Q2 FY2019Jun 30, 2019$11.02M-0.5%
Q1 FY2019Mar 31, 2019$10.69M-3.4%
Q4 FY2018Dec 31, 2018$10.28M-10.2%
Q3 FY2018Sep 30, 2018$10.58M-15.6%
Q2 FY2018Jun 30, 2018$11.08M-9.7%
Q1 FY2018Mar 31, 2018$11.06M-10.4%
Q4 FY2017Dec 31, 2017$11.45M-7.5%
Q3 FY2017Sep 30, 2017$12.53M+24.6%
Q2 FY2017Jun 30, 2017$12.27M–
Q1 FY2017Mar 31, 2017$12.34M–
Q4 FY2016Dec 31, 2016$12.39M–
Q3 FY2016Sep 30, 2016$10.06M–

More Enveric Biosciences figures

See a number that looks wrong?